insights_auto
为什么 ANW 下跌了 5.71%?
深入探索chevron_right
ANW:FRA
Immuron Ltd
€0.016
arrow_downward
-5.71%(-0.0010) 1 天
10月15日, GMT+2 22:00:00 · EUR
search
所有股票代码
| 股票代码 | 价格 | 涨跌额 | 涨跌幅 |
|---|
insights_auto正在为 ANW 生成关键数据洞见…
开盘价
€0.02
最高价
€0.02
最低价
€0.02
市值
934.54万
平均成交量
904.00
成交量
0.00
52 周最高价
€0.04
52 周最低价
€0.01
员工人数
8
开盘价
€0.02
最高价
€0.02
最低价
€0.02
市值
934.54万
平均成交量
904.00
成交量
0.00
52 周最高价
€0.04
52 周最低价
€0.01
员工人数
8
新闻报道
来自网络来源和新闻合作伙伴
资料
Immuron is a biotechnology company based in Melbourne, Australia. In 2008, the company changed its name to Immuron Limited, having previously operated as Anadis Limited.
Immuron is focused on antigen-primed and dairy-derived health products. Its proprietary technologies allow for rapid development of polyclonal antibody and other proteins-based solutions for a range of diseases. The company specialises in nutraceutical, pharmaceutical and therapeutic technology products for conditions such as oral and GI mucositis, avian influenza, E. coli travellers' diarrhoea and Anthrax containment.
In 2005, Anadis signed an agreement with Quebec's Baralex Inc. and Valeo Pharma Inc. for the distribution of Travelan, a product made by Anadis for the Canadian market. Wikipedia
Immuron Ltd简介